Insufficient scRNA-seq data for expression of CYP2A13 at single-cell level.
Insufficient scRNA-seq data for expression of CYP2A13 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
liver | 90% | 67.13 | 204 / 226 | 36% | 5.60 | 145 / 406 |
lung | 51% | 11.41 | 297 / 578 | 10% | 0.53 | 114 / 1155 |
uterus | 43% | 3.18 | 73 / 170 | 10% | 1.04 | 47 / 459 |
ovary | 39% | 1.44 | 71 / 180 | 9% | 0.31 | 39 / 430 |
bladder | 43% | 2.05 | 9 / 21 | 2% | 0.10 | 8 / 504 |
brain | 43% | 1.95 | 1127 / 2642 | 1% | 0.07 | 9 / 705 |
prostate | 29% | 1.43 | 70 / 245 | 0% | 0 | 0 / 502 |
breast | 15% | 0.59 | 69 / 459 | 6% | 0.69 | 68 / 1118 |
skin | 13% | 0.36 | 233 / 1809 | 0% | 0.01 | 1 / 472 |
blood vessel | 10% | 0.28 | 136 / 1335 | 0% | 0 | 0 / 0 |
peripheral blood | 10% | 0.37 | 90 / 929 | 0% | 0 | 0 / 0 |
esophagus | 8% | 0.25 | 120 / 1445 | 1% | 1.20 | 2 / 183 |
adipose | 9% | 0.24 | 111 / 1204 | 0% | 0 | 0 / 0 |
thymus | 9% | 0.26 | 60 / 653 | 0% | 0 | 0 / 605 |
intestine | 9% | 0.24 | 84 / 966 | 0% | 0.00 | 2 / 527 |
stomach | 6% | 0.15 | 23 / 359 | 2% | 0.03 | 6 / 286 |
pancreas | 4% | 0.09 | 14 / 328 | 2% | 0.10 | 4 / 178 |
spleen | 6% | 0.17 | 14 / 241 | 0% | 0 | 0 / 0 |
heart | 5% | 0.15 | 47 / 861 | 0% | 0 | 0 / 0 |
muscle | 5% | 0.13 | 41 / 803 | 0% | 0 | 0 / 0 |
kidney | 4% | 0.11 | 4 / 89 | 1% | 0.02 | 5 / 901 |
adrenal gland | 4% | 0.11 | 11 / 258 | 0% | 0.01 | 1 / 230 |
tonsil | 0% | 0 | 0 / 0 | 4% | 0.09 | 2 / 45 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0019373 | Biological process | epoxygenase P450 pathway |
GO_0046222 | Biological process | aflatoxin metabolic process |
GO_0006805 | Biological process | xenobiotic metabolic process |
GO_0009804 | Biological process | coumarin metabolic process |
GO_0043231 | Cellular component | intracellular membrane-bounded organelle |
GO_0005737 | Cellular component | cytoplasm |
GO_0005789 | Cellular component | endoplasmic reticulum membrane |
GO_0008389 | Molecular function | coumarin 7-hydroxylase activity |
GO_0004497 | Molecular function | monooxygenase activity |
GO_0005506 | Molecular function | iron ion binding |
GO_0008392 | Molecular function | arachidonic acid epoxygenase activity |
GO_0020037 | Molecular function | heme binding |
GO_0070330 | Molecular function | aromatase activity |
GO_0016712 | Molecular function | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen |
Gene name | CYP2A13 |
Protein name | Cytochrome P450 2A13 (EC 1.14.14.1) (CYPIIA13) |
Synonyms | |
Description | FUNCTION: Exhibits a coumarin 7-hydroxylase activity. Active in the metabolic activation of hexamethylphosphoramide, N,N-dimethylaniline, 2'-methoxyacetophenone, N-nitrosomethylphenylamine, and the tobacco-specific carcinogen, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone. Possesses phenacetin O-deethylation activity. . |
Accessions | ENST00000330436.4 Q16696 |